Aspire Private Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8
| Closed | -$1.55K | – | 211 |
|
|
2024
Q3 | $1.55K | Hold |
8
| – | – | ﹤0.01% | 566 |
|
|
2024
Q2 | $1.86K | Hold |
8
| – | – | ﹤0.01% | 563 |
|
|
2024
Q1 | $1.73K | Hold |
8
| – | – | ﹤0.01% | 590 |
|
|
2023
Q4 | $2.07K | Hold |
8
| – | – | ﹤0.01% | 560 |
|
|
2023
Q3 | $2.06K | Hold |
8
| – | – | ﹤0.01% | 561 |
|
|
2023
Q2 | $2.28K | Hold |
8
| – | – | ﹤0.01% | 532 |
|
|
2023
Q1 | $2.22K | Hold |
8
| – | – | ﹤0.01% | 531 |
|
|
2022
Q4 | $2.22K | Hold |
8
| – | – | ﹤0.01% | 517 |
|
|
2022
Q3 | $2K | Hold |
8
| – | – | ﹤0.01% | 502 |
|
|
2022
Q2 | $2K | Hold |
8
| – | – | ﹤0.01% | 480 |
|
|
2022
Q1 | $2K | Hold |
8
| – | – | ﹤0.01% | 484 |
|
|
2021
Q4 | $2K | Hold |
8
| – | – | ﹤0.01% | 505 |
|
|
2021
Q3 | $2K | Hold |
8
| – | – | ﹤0.01% | 478 |
|
|
2021
Q2 | $3K | Sell |
8
-53
| -87% | -$19.9K | ﹤0.01% | 444 |
|
|
2021
Q1 | $17K | Buy |
61
+50
| +455% | +$13.9K | 0.01% | 283 |
|
|
2020
Q4 | $3K | Hold |
11
| – | – | ﹤0.01% | 339 |
|
|
2020
Q3 | $3K | Sell |
11
-65
| -86% | -$17.7K | ﹤0.01% | 335 |
|
|
2020
Q2 | $21K | Buy |
+76
| New | +$21K | 0.01% | 189 |
|
|
2020
Q1 | – | Sell |
-8
| Closed | -$2K | – | 257 |
|
|
2019
Q4 | $2K | Hold |
8
| – | – | ﹤0.01% | 364 |
|
|
2019
Q3 | $2K | Sell |
8
-1
| -11% | -$250 | ﹤0.01% | 349 |
|
|
2019
Q2 | $2K | Hold |
9
| – | – | ﹤0.01% | 379 |
|
|
2019
Q1 | $2K | Hold |
9
| – | – | ﹤0.01% | 421 |
|
|
2018
Q4 | $3K | Buy |
+9
| New | +$3K | ﹤0.01% | 373 |
|